COVID-19 vaccines: early success and remaining challenges

被引：26
作者：
Bar-Zeev, Naor [1 ]
Inglesby, Tom [2 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Hlth Secur, Baltimore, MD 21205 USA
来源：
LANCET | 2020年 / 396卷 / 10255期
关键词：
D O I：
10.1016/S0140-6736(20)31867-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：868 / 869
页数：2
相关论文
共 7 条
  • [1] Vaccine confidence in the time of COVID-19
    Harrison, Emily A.
    Wu, Julia W.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2020, 35 (04) : 325 - 330
  • [2] An mRNA Vaccine against SARS-CoV-2-Preliminary Report
    Jackson, L. A.
    Anderson, E. J.
    Rouphael, N. G.
    Roberts, P. C.
    Makhene, M.
    Coler, R. N.
    McCullough, M. P.
    Chappell, J. D.
    Denison, M. R.
    Stevens, L. J.
    Pruijssers, A. J.
    McDermott, A.
    Flach, B.
    Doria-Rose, N. A.
    Corbett, K. S.
    Morabito, K. M.
    O'Dell, S.
    Schmidt, S. D.
    Swanson, P. A.
    Padilla, M.
    Mascola, J. R.
    Neuzil, K. M.
    Bennett, H.
    Sun, W.
    Peters, E.
    Makowski, M.
    Albert, J.
    Cross, K.
    Buchanan, W.
    Pikaart-Tautges, R.
    Ledgerwood, J. E.
    Graham, B. S.
    Beigel, J. H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20) : 1920 - 1931
  • [3] COVID-19 vaccine trials should seek worthwhile efficacy
    Krause, Philip
    Fleming, Thomas R.
    Longini, Ira
    Henao-Restrepo, Ana Maria
    Peto, Richard
    [J]. LANCET, 2020, 396 (10253) : 741 - 743
  • [4] Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
    Lambert, Paul-Henri
    Ambrosino, Donna M.
    Andersen, Svein R.
    Baric, Ralph S.
    Black, Steven B.
    Chen, Robert T.
    Dekker, Cornelia L.
    Didierlaurent, Arnaud M.
    Graham, Barney S.
    Martin, Samantha D.
    Molrine, Deborah C.
    Perlman, Stanley
    Picard-Fraser, Philip A.
    Pollard, Andrew J.
    Qin, Chuan
    Subbarao, Kanta
    Cramer, Jakob P.
    [J]. VACCINE, 2020, 38 (31) : 4783 - 4791
  • [5] Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
    Logunov, Denis Y.
    Dolzhikova, Inna V.
    Zubkova, Olga V.
    Tukhvatullin, Amir I.
    Shcheblyakov, Dmitry V.
    Dzharullaeva, Alina S.
    Grousova, Daria M.
    Erokhova, Alina S.
    Kovyrshina, Anna V.
    Botikov, Andrei G.
    Izhaeva, Fatima M.
    Popova, Olga
    Ozharovskaya, Tatiana A.
    Esmagambetov, Ilias B.
    Favorskaya, Irina A.
    Zrelkin, Denis I.
    Voronina, Daria V.
    Shcherbinin, Dmitry N.
    Semikhin, Alexander S.
    Simakova, Yana V.
    Tokarskaya, Elizaveta A.
    Lubenets, Nadezhda L.
    Egorova, Daria A.
    Shmarov, Maksim M.
    Nikitenko, Natalia A.
    Morozova, Lola F.
    Smolyarchuk, Elena A.
    Kryukov, Evgeny V.
    Babira, Vladimir F.
    Borisevich, Sergei V.
    Naroditsky, Boris S.
    Gintsburg, Alexander L.
    [J]. LANCET, 2020, 396 (10255) : 887 - 897
  • [6] The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic
    Won, Jung-Hyun
    Lee, Howard
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 17
  • [7] Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
    Zhu, Feng-Cai
    Guan, Xu-Hua
    Li, Yu-Hua
    Huang, Jian-Ying
    Jiang, Tao
    Hou, Li-Hua
    Li, Jing-Xin
    Yang, Bei-Fang
    Wang, Ling
    Wang, Wen-Juan
    Wu, Shi-Po
    Wang, Zhao
    Wu, Xiao-Hong
    Xu, Jun-Jie
    Zhang, Zhe
    Jia, Si-Yue
    Wang, Bu-Sen
    Hu, Yi
    Liu, Jing-Jing
    Zhang, Jun
    Qian, Xiao-Ai
    Li, Qiong
    Pan, Hong-Xing
    Jiang, Hu-Dachuan
    Deng, Peng
    Gou, Jin-Bo
    Wang, Xue-Wen
    Wang, Xing-Huan
    Chen, Wei
    [J]. LANCET, 2020, 396 (10249) : 479 - 488
1